Billionaire David Einhorn's 10 Stock Picks with Huge Upside Potential
David Einhorn is a widely renowned hedge fund manager who co-founded Greenlight Capital in 1996.
Roivant Sciences Ltd. (ROIV)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Impax Asset Management Ian Simm | 2,000,000 | $20,180,000 | 0.12% | |
| 2. | Leucadia National Ian Cumming And Joseph Steinberg | 0 | $0 | 0% | |
| 3. | ZWEIG DIMENNA PARTNERS Joe Dimenna | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.00 | 4,000,000 | Large Shareholder | 102,849,443 | 2022-11-10 | Filing | |
| $3.91 | 8,600 | Large Shareholder | 98,849,443 | 2022-04-25 | Filing | |
| $3.83 | 31,685 | Large Shareholder | 98,840,843 | 2022-04-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.18 | 625,000 | 39,174,611 | 2025-05-07 | Filing | ||
| $11.47 | 273,959 | 39,799,611 | 2025-05-06 | Filing | ||
| $10.22 | 100,000 | 1,116,345 | 2025-04-21 | Filing | ||
| $10.82 | 434,478 | 1,127,290 | 2025-03-24 | Filing | ||
| $11.06 | 315,522 | 959,457 | 2025-03-20 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 41,659,488 | $420,344,233 | 0.01% | |
| 2. | 40,767,590 | $411,344,983 | 0.01% | |
| 3. | 4,000,181 | $40,361,821 | 0.01% | |
| 4. | 2,847,625 | $28,732,536 | 0.01% | |
| 5. | 2,433,386 | $24,552,865 | 0% |
News See All
Billionaire Andreas Halvorsen's 10 Stock Picks With Huge Upside Potential
Ole Andreas Halvorsen is one of the prominent names among former employees of Julian Robertson's Tiger Management.
Top 9 Healthcare Stocks to Buy According to Billionaire David Einhorn
Wall Street has come down crashing on President Donald Trump’s sweeping tariffs, raising the risk of a trade war that could push the global economy into recession.
10 Best Low Priced Growth Stocks To Invest In
Low priced stocks usually fall under the small to mid-cap size category.
10 Best Mid Cap Biotech Stocks to Buy
On March 6, Jared Holz, Mizuho health care equity strategist, appeared on CNBC's 'Power Lunch' to discuss investing in biotech and the oversaturation in the sector.
10 Best Stocks to Buy According to Billionaire David Einhorn
David Einhorn is a highly regarded hedge fund manager, who co-founded Greenlight Capital in 1996.
Does Roivant (ROIV) Offer an Attractive Risk Reward Opportunity?
Tourlite Capital Management, an investment management firm, released its fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 Cash-Rich Mid Cap Stocks To Buy Now
Cash flow is the money moving in and out of a business over a set period. It is important because it shows how much cash a company actually has on hand, rather than just looking at profits on paper.
10 Cheap Biotech Stocks to Invest in Now
Biotechnology stocks are among the most volatile in the market due to their high risk.
Roivant Sciences Ltd. (NASDAQ:ROIV) Q3 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to a Roivant Sciences Ltd. second quarter 2024 earnings call. At this time, all participants are in a listen-only mode.